Assistant Professor of Radiation Oncology

Special Interests:

• Thoracic Malignancies
• GI Malignancies
• Intensity Modulated Radiation Therapy (IMRT)
• Translational research focused on mechanisms and mitigators of acute and delayed radiation injury

Medical Degree: University of Maryland School of Medicine

Residency: University of Chicago, Department of Radiation and Cellular Oncology

Biography:

Selected Peer-Reviewed Journal Articles

Myerson R, Garofalo MC, el Naqa I, Abrams R, Bosch W, Das P, Gunderson L, Hong T, Kim J, Willett CG, Kachnic LA. Clinical target volumes for intensity modulated radiation therapy (IMRT) planning in anorectal cancer: an RTOG expert consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 2008 (accepted for publication).

Holanda D, Zhao MY, Rapoport AP, Garofalo M, Chen Q, Zhao XF. Primary gastric T-cell lymphoma mimicking marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. J Hematopathol 2008 (in press).

Garofalo MC, Nazareth DP, Errens M, D'Souza W, Regine WF. A comparison of 3D-CRT and IMRT planning for patients with T3Nx or T4Nx mid/distal rectal cancers: potential for small bowel sparing and reduced GI toxicity (abstract 2179). Int J Radiat Oncol Biol Phys 2008 Sept;72(1);Suppl 1:S250.

Yovino S, Garofalo MC, David V, Poppe M, Jabbour S, Hanna N, Alexander R, Pandya N, Doyle A, Regine WF. Intensity-modulated radiation therapy (IMRT) significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers: a multi-institutional experience (abstract 2189). Int J Radiat Oncol Biol Phys 2008 Sept;72(1);Suppl 1:S254.

Liu B, Garofalo M, Lerma F. Confirmation of SBRT of the head of pancreas cancer using a non- rigid image registration (abstract 2828). Int J Radiat Oncol Biol Phys 2008 Sept;72(1);Suppl 1:S539.

Myerson R, Garofalo M, El Naqa I, Abrams RA, Apte A, Bosch W, Das P, Gunderson L, Hong T, Kim J, Willett CG, Kachnic LA. Elective clinical target volumes for conformal therapy in anorectal cancer: An RTOG consensus panel contouring atlas (abstract 156). Int J Radiat Oncol Biol Phys 2008 Sept;72(1);Suppl 1:S71.

Regine WF, Hanna NN, Wong R, Major P, Garofalo MC, Alexander RA, Pandya N, Kennedy NL, Mohiuddin M. Radiation therapy (RT) as a chemopotentiator of gemcitabine (G) in patients with advanced pancreatic cancer: a multi-institutional phase II study (abstract 2198). Int J Radiat Oncol Biol Phys 2008 Sept;72(1);Suppl 1:S258-259.

Koshy M, Zhao F, Garofalo MC. Primary MALT lymphoma of the gallbladder: case report and review of the literature. Journal of Gastrointestinal and Liver Diseases 2008 Jun 17(2):207-10.

Chumsri S, Zhao M, Garofalo M, Burger A, Hamburger A, Zhao F, Rapoport A. Inhibition of the mammalian target of rapamycin (mTOR) in a case of refractory primary cutaneous anaplastic large cell lymphoma (letter to the editor). Leukemia and Lymphoma 2008 Feb;49(2):359-61.

Katadare M, Efimova EV, Labay E, Khodarev NN, Darga TE, Garofalo M, Nakamura S, Kufe DW, Posner M, Weichselbaum RR. Diverse TNFα-induced death pathways are enhanced by inhibition of NF-kappaB. Int J Oncol 2007 Dec;31(6):1519-28.

Garofalo MC, Nichols EM, Regine WR. Optimal adjuvant therapy for resected pancreatic cancer: chemotherapy or chemoradiotherapy? GCR 2007 Sep/Oct;1(5):182-187.

Mirmiran A, Yechieli R, Garofalo MC, D'Souza W, Dhople A, DeYoung CM, Suntharalingam M. High-dose hypofractionated stereotactic body radiation therapy (SBRT) in the treatment of patients with primary non-small cell lung cancer (abstract 2498) Int J Radiat Oncol Biol Phys 2007 Nov;69(3);Suppl 1:S477-478.

Regine WF, Hanna N, Garofalo MC, Doyle A, Arnold S, Kataria R, Simms J, Mohiuddin. Radiation therapy (RT) as a chemosensitizer of gemcitabine (G) in patients with metastatic/unresectable tumors of the gastrointestinal (GI) tract - a phase I/II study exploring a new treatment paradigm. (abstract 23) Int J Radiat Oncol Biol Phys 2005 63(2);Suppl 1:S13-14.

Milano MT, Chmura SJ, Garofalo MC, Rash C, Roeske JC, Kwon O, Connell PP, Heimann R. Intensity Modulated Radiation Therapy (IMRT) in the Treatment of Pancreatic and Bile Duct Malignancies: Toxicity and Outcome. Int J Radiat Oncol Biol Phys 2004 Jun 1;59(2):445-53.

Chmura SJ, Garofalo M, Salama J, Silverberg W, Oh J, Roeske JC. Does the Dose Protraction Inherent to IMRT Decrease Tumor Cell Killing In Vitro (abstract 1107). Int J Radiat Oncol Biol Phys. 2004 60(1) Suppl 1:S319-S320.

Garofalo MC, Abrams RA, Regine WF. Adjuvant Therapy for Pancreatic Cancer: No 'Definite' Standard. Oncology 2007 May;21(6):726-30.

Kwok Y, DeYoung C, Garofalo MC, Dhople A, Regine W. Radiation Oncology Emergencies. Hematol Oncol Clin North Am 2006 Apr;20(2):505-22.

Garofalo MC, Flannery T, Regine W. The Case for Adjuvant Chemoradiation in Pancreatic Cancer. Best Clinical Practice & Research: Clinical Gastroenterology. 2006 Apr;20(2):403-416.

Garofalo MC, Kwok Y, Regine WR. The evolving role of postoperative adjuvant radiation therapy for pancreatic cancer. Surg Oncol Clin N Am 2004 Oct;13(4):589-604.

Kao J, Mantz C, Garofalo M, Milano M, Vijayakumar S, Jani A. Treatment-related Sexual Dysfunction in Male Nonprostate Pelvic Malignancies. Sexuality and Disability. 2003 Vol 21(1):3-20.

Kao J, Garofalo MC, Milano M, Chmura S, Citron J, Haraf D. Reirradiation of Recurrent and Second Primary Head and Neck Malignancies: A Comprehensive Review. Cancer Treat Rev. 2003 Feb;29(1):21-30.

Garofalo MC, Haraf DJ. Reirradiation: A Potentially Curative Approach to Locally or Regionally Recurrent Head and Neck Cancer. Curr Opin Oncol 2002 May;14(3):330-3.

Contact Information:

Patient Appointments/General Information
(410) 328-2999 or (800) 492-5538

Doctors Only
(800) 373-4111